Which of the following viruses could be reactivated under immunosuppressive therapy?

Correct Answer: D

Rationale: The correct answer is D, "None of the above," because viruses like Parotitidis (mumps), Rubella, and Influenza A are not typically associated with reactivation under immunosuppressive therapy. Reactivation is more commonly seen in latent viruses like herpesviruses (e.g., herpes simplex, varicella-zoster), cytomegalovirus, and Epstein-Barr virus. These viruses can remain dormant in the body and reactivate when the immune system is compromised. Therefore, the correct answer is D, as the viruses mentioned in choices A, B, and C do not fit the criteria for reactivation under immunosuppressive therapy.

Correct Answer: C

Rationale: The correct answer is C because plasmids do not encode essential bacterial properties. They are non-essential, extra-chromosomal DNA molecules that can replicate independently within bacterial cells. Plasmids mainly contain genes for antibiotic resistance, genetic transfer, and other specific functions. Choice A is correct as many plasmids do carry antibiotic resistance genes. Choice B is also accurate as plasmids are indeed smaller, circular, and exist outside the bacterial chromosome. Choice D is true as plasmids can facilitate bacterial conjugation, allowing the transfer of genetic material between bacteria.

Correct Answer: D

Rationale: The correct answer is D: Fungi do not stain in the gram staining method because they have a unique cell wall composition different from bacteria. Fungi have chitin in their cell walls, which is not easily stained by the gram staining process. This method primarily targets the peptidoglycan layer present in bacterial cell walls. Therefore, fungi will not take up the stain and will remain colorless. The other choices (A: Blue-purple, B: Red, C: Silver) are incorrect because they describe colors that are associated with staining results for bacteria, not fungi.

Correct Answer: D

Rationale: The correct answer is D: All are correct. Patients planned for treatment with monoclonal antibodies should be tested for HBV, HCV, and M. tuberculosis due to the risk of reactivation of these infections during treatment. HBV and HCV reactivation can lead to severe liver damage, while M. tuberculosis reactivation can cause serious respiratory complications. Testing for all three infections helps in identifying and managing any pre-existing infections to ensure patient safety during monoclonal antibody treatment. Choices A, B, and C are incorrect because each of these infections presents specific risks that need to be assessed before initiating monoclonal antibody therapy.

Correct Answer: D

Rationale: After the transfer of the F plasmid from the donor to the recipient cell, the correct answer is D. This is because the F plasmid carries genes for conjugation, allowing the recipient cell to become F+ (containing the F plasmid). The donor cell remains F. Choice A is incorrect as the outcome can be predicted based on the transfer of the F plasmid. Choice B is incorrect because the donor cell does not become F after transferring the F plasmid. Choice C is incorrect as only the recipient cell becomes F+, not both cells.